[HTML][HTML] Clinical development of new drug–radiotherapy combinations

…, M Smitt, J Staffurth, IJ Stratford… - Nature reviews Clinical …, 2016 - nature.com
In countries with the best cancer outcomes, approximately 60% of patients receive radiotherapy
as part of their treatment, which is one of the most cost-effective cancer treatments. …

[PDF][PDF] Targeting gene therapy to cancer: a review

GU Dachs, GJ Dougherty, IJ Stratford… - Oncology …, 1997 - researchgate.net
In recent years the idea of using gene therapy as a modality in the treatment of diseases other
than genetically inherited, monogenic disorders has taken root. This is particularly obvious …

[HTML][HTML] Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers

…, CM Nutting, A Oliver, R Plummer, IJ Stratford… - British journal of …, 2011 - nature.com
There is a growing appreciation of the potential value of combining novel molecularly-targeted
drugs with radiotherapy or chemoradiotherapy. Such approaches have the potential to …

Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth

…, LG Nicholls, AL Harris, IJ Stratford… - Proceedings of the …, 1997 - National Acad Sciences
Recent studies of tissue culture cells have defined a widespread system of oxygen-regulated
gene expression based on the activation of a heterodimeric transcription factor termed …

[HTML][HTML] Guidelines for the welfare and use of animals in cancer research

…, LR Kelland, V Robinson, IJ Stratford… - British journal of …, 2010 - nature.com
Animal experiments remain essential to understand the fundamental mechanisms underpinning
malignancy and to discover improved methods to prevent, diagnose and treat cancer. …

Acquired resistance to fractionated radiotherapy can be overcome by concurrent PD-L1 blockade

…, C McKenna, S Jones, EJ Cheadle, IJ Stratford… - Cancer research, 2014 - AACR
Radiotherapy is a major part in the treatment of most common cancers, but many patients
experience local recurrence with metastatic disease. In evaluating response biomarkers, we …

Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced …

…, CC Wycoff, J Pastorek, PJ Ratcliffe, IJ Stratford… - Cancer research, 2001 - AACR
There is increasing evidence that hypoxia-regulated gene expression influences tumor
aggressiveness, contributing to the poorer outcome of patients with hypoxic tumors. The role of …

Anticancer chemosensitization and radiosensitization by the novel poly (ADP-ribose) polymerase-1 inhibitor AG14361

…, DR Newell, E Notarianni, IJ Stratford… - Journal of the …, 2004 - academic.oup.com
IJ Stratford and KJ Williams are conducting research sponsored by Agouron Pfizer. … Williams
KJ, Telfer BA, Stratford IJ, Wedge SR. ZD1839 (‘Iressa’), a specific oral epidermal growth …

Hypoxia-mediated down-regulation of Bid and Bax in tumors occurs via hypoxia-inducible factor 1-dependent and-independent mechanisms and contributes to drug …

…, C Miller, C Demonacos, IJ Stratford… - … and cellular biology, 2004 - Taylor & Francis
… Robinson, KJ Williams, and IJ Stratford, personal communication). Oxygen deprivation … ,
Sheridan MR, van der Kogel AJ, Harris AL, and Stratford IJ. 2002. A protective role for HIF-1 in …

Targeting gene expression to hypoxic tumor cells

…, JD Firth, PJ Ratcliffe, KMS Townsend, IJ Stratford… - Nature medicine, 1997 - nature.com
Solid tumors with areas of low oxygen tension (hypoxia) have a poor prognosis, as celts in
this environment often survive radiation and chemotherapy. In this report we describe how …